David Humphrey's most recent trade in Ensysce Biosciences Inc was a trade of 80,000 Stock Option done . Disclosure was reported to the exchange on Feb. 17, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ensysce Biosciences Inc | David Humphrey | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 80,000 | 80,000 | - | - | Stock Option | |
| Ensysce Biosciences Inc | David Humphrey | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 275,000 | 275,000 | - | - | Stock Option | |
| Ensysce Biosciences Inc | David Humphrey | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 50,000 | 50,000 | - | 0 | Common Stock | |
| Gen Digital | David W. Humphrey | Director | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 10 Sep 2020 | 367,216,000 | - | - | - | 2.000% Convertible Senior Notes due 2022 |